MaximBio & Thomas Scientific Ink Marketing Agreement for ClearDetectTM
Today, Maxim Biomedical (MaximBio), a leading diagnostic healthcare company and manufacturer of trusted diagnostic solutions announced a comprehensive Marketing and Distribution Agreement with Thomas Scientific for the ClearDetectTM COVID-19 Antigen Home Test (ClearDetectTM) which received Emergency Use Authorization (EUA) from the U.S. Food…
MYND Diagnostics begins Clinical Research on Alzheimer’s Disease
MYND Diagnostics begins Clinical Research on Alzheimer’s Disease
The Company will be initiating a clinical validation study on the use of its proprietary biomarker testing in Alzheimer’s Disease...
Medivolve Announces Q3 2021 Results
Medivolve Announces Q3 2021 Results
Revenue was $25.3 million in the third quarter of 2021, up 575%, compared to $3.7 million over the prior three-month period ending June 30, 2021....
InfuSystem Reports Third Quarter 2021 Financial Results
InfuSystem Reports Third Quarter 2021 Financial Results
Selected as Supplier of Infusion Pump Biomedical Services for Leading Global Medical Technology and Diagnostic Equipment Company Worth Expected $14...
Ellie Diagnostics Raises Equity from Avego Healthcare Capital
Ellie Diagnostics Raises Equity from Avego Healthcare Capital
Ellie and Avego unite to provide innovative diagnostic solutions to veterinarians Ellie Diagnostics is pleased to announce a new capital...